Nano-enabled pharmacogenomics: revolutionizing personalized drug therapy

Area of Science:

• Pharmacogenomics and Nanotechnology
• Personalized Medicine
• Genomic Sciences

Background:

• Pharmacogenomics evolution and genomic science advancements.
• Challenges in drug development and personalized medicine implementation.
• Limitations of traditional pharmacogenomics, including drug resistance and delivery issues.

Purpose of the Study:

• To review the integration of nanotechnology with pharmacogenomics.
• To explore advancements in gene editing tools and nanoparticle delivery systems.
• To discuss the impact of nanotechnology on personalized medicine and drug development.

Main Methods:

• Comprehensive literature review of pharmacogenomics and nanotechnology.
• Analysis of gene editing tools and nanoparticle delivery mechanisms.
• Examination of case studies and current clinical applications.

Main Results:

• Nanotechnology overcomes pharmacogenomic challenges like drug resistance and improves targeted delivery.
• Integration with AI and machine learning enhances nano-enabled pharmacogenomics.
• Ethical and regulatory aspects of these emerging technologies are considered.

Conclusions:

• Nano-enabled pharmacogenomics offers significant potential for personalized medicine and cancer treatment.
• Further advancements and collaborations are crucial to maximize the potential of this field.
• Nanotechnology integration is key to overcoming past limitations in pharmacogenomics.